SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...
Pregnant people are routinely offered blood-based, cell-free (cf) DNA sequencing to screen for fetal abnormalities. Unexpected findings may be a result of tumor DNA in the maternal blood sample ...
The site seeks to educate prospective parents on the benefits of prenatal genetic screening, dispelling common myths and offering guidance on screening options and potential next steps for high ...
The site features real-life patient stories to illustrate how prenatal screening can help parents-to-be manage their pregnancies. “Many patients don’t initially understand the importance of ...
The company’s “Fetal fraction amplification enables accurate prenatal cell-free DNA (cfDNA) screening at eight weeks gestation” study was awarded SMFM’s “Dru Carlson Memorial Award for ...